Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Lancet Oncol. 2010 Aug 3;11(9):827–834. doi: 10.1016/S1470-2045(10)70167-4

Table 1.

Characteristics of HBsAg positive and HBsAg negative subjects in the Korean Cancer Prevention Study cohort (N=603,585)

Characteristic HBsAg+ (N=53,045) HBsAg− (N=550,540)
Sex, n (%)
 Male 44,801 (84.5) 430,766 (78.2)
 Female 8,244 (15.5) 119,774 (21.8)
Age in years at testing, n (%)
 30–39 26,567 (50.1) 245,172 (44.5)
 40–49 17,478 (33.0) 186,463 (33.9)
 50–59 8307 (15.7) 106,245 (19.3)
 60+ 693 (1.3) 12,660 (2.3)
 Median age 39 41
Calendar year at testing, n (%)
 1992 46,015 (86.8) 446,841 (81.2)
 1993 1269 (2.4) 27,349 (5.0)
 1994 4962 (9.4) 61,242 (11.1)
 1995 799 (1.5) 15,108 (2.7)
Alcohol use in grams/day, n (%)
 0 18,983 (35.8) 191,731 (34.8)
 1–24.9 24,998 (47.1) 263,418 (47.9)
 25–49.9 5314 (10.0) 56,196 (10.2)
 50–99.9 2833 (5.3) 29,209 (5.3)
 100+ 917 (1.7) 9,986 (1.8)
ALT, n (%)
 Normal 40,394 (76.2) 495,880 (90.1)
 Abnormal 12,651 (23.9) 54,660 (9.9)
AST, n (%)
 Normal 42,788 (80.7) 512,626 (93.1)
 Abnormal 10,257 (19.3) 37,914 (6.9)

Abbreviations: HBsAg hepatitis B surface antigen, ALT alanine aminotransferase, AST aspartate aminotransferase